UTHR FY 2019 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.4B-11.0% YoY

Gross Profit

$1.3B91.9% margin

Operating Income

-$188M-12.9% margin

Net Income

-$105M-7.2% margin

EPS (Diluted)

$-2.39

Cash Flow

Operating Cash Flow

-$207M

Free Cash Flow

-$290M

Stock-Based Comp.

$45M

Balance Sheet

Total Assets

$3.9B

Total Liabilities

$1.1B

Stockholders' Equity

$2.8B

Cash & Equivalents

$738M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.4B	$1.6B	-11.0%
Gross Profit	$1.3B	$1.4B	-6.9%
Operating Income	-$188M	$805M	-123.3%
Net Income	-$105M	$589M	-117.7%